Search results for "ERAS"

showing 10 items of 4431 documents

Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women

2007

TRAIL is a potent inducer of apoptosis in malignant but not in normal cells. TRAIL binds to the proapoptotic death receptor DR4 and DR5 as well as to the decoy receptors DcR1 and DcR2. To evaluate the involvement of TRAIL receptor genes in breast cancer, we carried out a case-control study of eight selected polymorphisms in a large sample of Spanish women. Three of the eight selected SNPs (626G/C and 1322G/A in DR4 and 2699A/G in DcR2) showed some evidence of different genotype distributions in a random selection of 535 cases and 480 controls and were therefore studied in our entire sample (1008 cases and 768 controls). For the two DR4 polymorphisms, no differences in genotype or haplotype …

AdultUntranslated regionCancer ResearchLinkage disequilibriumBreast NeoplasmsSingle-nucleotide polymorphismBiologyPolymerase Chain ReactionPolymorphism Single NucleotideBreast cancerGenotypeGeneticsmedicineHumansDecoy receptorsskin and connective tissue diseasesReceptorAgedHaplotypeAge FactorsGeneral MedicineMiddle Agedmedicine.diseaseReceptors TNF-Related Apoptosis-Inducing LigandOncologySpainImmunologyFemaleCancer Biomarkers
researchProduct

Mosaicism due to postzygotic mutations in women with focal dermal hypoplasia

2019

International audience; Focal dermal hypoplasia (FDH, Goltz syndrome, MIM: #305600) constitutes a rare multisystem genetic disorder of the skin, skeleton, teeth and eyes with considerable variation in the clinical features. FDH is transmitted as an X-linked dominant trait and is caused by mutations in PORCN. In males, hemizygous PORCN mutations are lethal in utero. Around 300 cases have been reported in the literature to date. About 10% of them are males presenting either Klinefelter syndrome (karyotype 47, XXY) or mosaicism of a postzygotic mutation. Here we describe four cases of women with typical features of FDH, in whom a PORCN mutation was found in DNA from affected cutaneous tissue b…

AdultZygoteDNA Mutational AnalysisDermatologyBiologyPostzygotic mutationmedicine.disease_causePORCNYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansMissense mutationGoltz syndromeSkinGeneticsMutationMosaicismMouth MucosaGenetic disorderHigh-Throughput Nucleotide SequencingMembrane Proteinscutaneous mosaicismKaryotypemedicine.diseaseFocal dermal hypoplasia3. Good healthPORCNfocal dermal hypoplasiaFemaleKlinefelter syndromeAcyltransferases[SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/DermatologyBritish Journal of Dermatology
researchProduct

Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.

1995

The absence of breast development and the prevention of osteoporosis in Ullrich-Turner syndrome (UTS) require oestrogen/gestagen substitution therapy. In 8 out of 35 (23%) patients with UTS treated with conjugated equine oestrogens and cyclically with norethisterone acetate, the serum liver enzymes increased to conspicuous levels (AST 35; 20-73 U/l, ALT 92; 37-141 U/l, GGT 77; 25-227 U/l, [median; min-max]). These findings were compared with those in 41 tall girls who received a six-fold larger dose of conjugated equine oestrogens for the reduction of final height. None of these 41 girls showed abnormal serum liver enzyme levels. The conspicuous rise in serum liver enzyme levels occurred in…

Adultmedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentOsteoporosisTurner SyndromeLiver Function TestsInternal medicineTurner syndromeBiopsymedicineHumansAspartate AminotransferasesSexual MaturationChildChemotherapyEstrogens Conjugated (USP)medicine.diagnostic_testbusiness.industryEstrogen Replacement TherapyAlanine Transaminasegamma-Glutamyltransferasemedicine.diseaseNorethisterone acetateBody HeightNorethindrone AcetateEndocrinologyEstrogenPediatrics Perinatology and Child HealthToxicityFemaleNorethindroneLiver function testsbusinessmedicine.drugFollow-Up StudiesEuropean journal of pediatrics
researchProduct

Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.

2006

Objective: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, is a novel cardiovascular risk factor produced by endothelial cells. ADMA levels are mainly regulated by the activity of dimethylarginine dimethylaminohydrolases (DDAH). Endothelial release of ADMA is increased in the presence of oxidized LDL cholesterol (oxLDL), whereas estrogens stimulate NO production by endothelial cells by increasing both expression and activity of NO synthase and by reducing ADMA levels. Thus, the aim of the present study was to evaluate the estradiol effects on the DDAH/ADMA/NO pathway in cultured human umbilical vein endothelial cells (HUVEC) exposed to LDL. Methods…

Adultmedicine.medical_specialtyEndotheliumPhysiologymedicine.drug_classImmunoblottingGene ExpressionBiologyArginineNitric OxideUmbilical veinNitric oxideAmidohydrolaseschemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineElectrochemistryHumansRNA MessengerCells CulturedChromatography High Pressure LiquidAnalysis of VarianceEstradiolReverse Transcriptase Polymerase Chain ReactionEndothelial CellsEndothelial stem cellNitric oxide synthaseLipoproteins LDLmedicine.anatomical_structureEndocrinologychemistryCell cultureEstrogenbiology.proteinEndothelium VascularNitric Oxide SynthaseCardiology and Cardiovascular MedicineAsymmetric dimethylarginineCardiovascular research
researchProduct

6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease.

2005

Background & Aims: Azathioprine is the gold standard for immunosuppressive therapy in Crohn's disease (CD) and its molecular mechanism of action is caused by the metabolite 6-thioguanosine triphosphate (TGTP). In this study we assessed the impact of TGTP levels for monitoring of azathioprine therapy. Methods: A novel, highly sensitive assay was established to measure levels of TGTP and its precursors 6-thioguanosine monophosphates and 6-thioguanosine diphosphates (TGDP) in red blood cells from 50 CD patients. The results were correlated with clinical outcome. Results: TGTP levels could be quantified in 47 patients and a subgroup of these patients showed significantly high levels of TGDP. 6-…

Adultmedicine.medical_specialtyErythrocytesMetaboliteAzathioprineInflammatory bowel diseaseGastroenterologyGuanosine Diphosphatechemistry.chemical_compoundCrohn DiseaseInternal medicineAzathioprinemedicineHumansCrohn's diseaseHepatologyThiopurine methyltransferasebiologybusiness.industryGastroenterologyAzathioprine therapyAntibodies MonoclonalThionucleotidesmedicine.diseaseInfliximabGuanine NucleotidesInfliximabRed blood cellmedicine.anatomical_structurechemistryImmunologybiology.proteinbusinessBiomarkersImmunosuppressive Agentsmedicine.drugClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct

Tyrosine hydroxylase Val-81-Met polymorphism associated with early-onset alcoholism

2005

The present study examined the association of the Tyrosine hydroxylase Val-81-Met polymorphism with alcohol dependence. One hundred and fifty-nine patients in a psychiatric unit with alcohol dependence were genotyped as well as 92 healthy volunteers. The Val allele was more frequent in patients with alcohol dependence (69.5%) than in controls (62.5%). This effect was largely due to the association with early-onset alcoholism (77.8%), whereas no difference was noted between late-onset patients and controls. Our results suggest a role for tyrosine hydroxylase in early-onset alcoholism.

Adultmedicine.medical_specialtyGenotypeTyrosine 3-MonooxygenaseMutation MissensePolymerase Chain ReactionPolymorphism Single Nucleotidechemistry.chemical_compoundMethionineReference ValuesInternal medicineGenotypeGeneticsHumansMedicineMissense mutationAge of OnsetAlleleBiological PsychiatryGenetics (clinical)DNA PrimersEarly onsetMethionineBase SequenceTyrosine hydroxylasebusiness.industryAlcohol dependenceValineAlcoholismPsychiatry and Mental healthEndocrinologychemistryAge of onsetbusinessPolymorphism Restriction Fragment LengthPsychiatric Genetics
researchProduct

Inducible nitric oxide synthase in skeletal muscle of patients with chronic heart failure

1998

Abstract Objectives. The expression and localization of inducible nitric oxide (NO) synthase (NOS II) was evaluated as a source of NO which has been shown to affect muscle contraction. Background. Advanced stages of chronic heart failure are associated with systemic activation of cytokines which have been shown to stimulate the expression of NOS II in various cell types, including myocytes. We hypothesized that systemic cytokine activation could lead to expression of NOS II in skeletal muscle of patients with chronic heart failure. Methods. Skeletal muscle specimens were obtained by percutaneous needle biopsy in six normal volunteers and eight patients with heart failure (New York Heart Ass…

Adultmedicine.medical_specialtyHeart diseaseGene ExpressionNitric Oxide Synthase Type IIPolymerase Chain ReactionNitric oxidechemistry.chemical_compoundInternal medicineGene expressionmedicineHumansMyocyteRNA MessengerMicroscopy ImmunoelectronMuscle SkeletalHeart Failurebiologybusiness.industrySkeletal muscleRNA-Directed DNA PolymeraseMiddle Agedmedicine.diseaseNitric oxide synthaseEndocrinologymedicine.anatomical_structurechemistryHeart failureChronic Diseasebiology.proteinNitric Oxide Synthasemedicine.symptombusinessCardiology and Cardiovascular MedicineMuscle contractionJournal of the American College of Cardiology
researchProduct

Oxidative stress after moderate to extensive burning in humans.

2000

Lipid peroxidation products, lipid antioxidants, and hematologic and blood chemistry changes were evaluated in plasma of patients after acute burning injury involving 10% (n=8), 20% (n=8), and 40% (n=5) of total body surface area (TBSA), 24 h after burning (baseline) up to 30 days after. Markedly increased plasma levels of malondialdehyde (MDA) were observed at baseline in all patients, according to the extent of the injury, then the values declined progressively. However, levels of MDA remained above normal up to 30 days even in less injured patients. On the other hand, the plasma level of conjugated diene lipid hydroperoxides was only slightly higher than control at the baseline, then dro…

Adultmedicine.medical_specialtyLipid PeroxidesErythrocytesTime FactorsAdolescentmedicine.medical_treatmentmedicine.disease_causeBiochemistryLipid peroxidationchemistry.chemical_compoundInternal medicineMalondialdehydemedicineHumansVitamin EAspartate AminotransferasesChildVitamin AAgedThermal injuryChemistryCholesterolVitamin EAlanine TransaminaseGeneral MedicineMiddle AgedMalondialdehydebeta CaroteneOxidative StressEndocrinologyCholesterolBiochemistryBlood chemistryLiverErythrocyte CountLipid PeroxidationBurnsTotal body surface areaOxidative stressFree radical research
researchProduct

A further patient with genitopatellar syndrome requiring multidisciplinary management.

2020

Adultmedicine.medical_specialtyMEDLINEKidneyPathology and Forensic MedicineCraniofacial AbnormalitiesMultidisciplinary approachIntellectual DisabilitymedicineHumansGenetic TestingIntensive care medicineChildGenetics (clinical)Histone AcetyltransferasesPatient Care Teambusiness.industryDisease ManagementFaciesGeneral MedicineExonsPatellamedicine.diseaseCombined Modality TherapyRadiographyPhenotypeTreatment OutcomeUrogenital AbnormalitiesPediatrics Perinatology and Child HealthMutationScrotumGenitopatellar syndromeFemaleInterdisciplinary CommunicationAnatomyPsychomotor DisordersbusinessClinical dysmorphology
researchProduct

Lack of modulating effects of the COMT Val158Met polymorphism on the association of serious life events (SLE) and impulsivity in patients with Border…

2009

Adultmedicine.medical_specialtyPolymorphism GeneticLife eventsValineCatechol O-MethyltransferaseImpulsivitymedicine.diseaseLife Change EventsPsychiatry and Mental healthMethionineBorderline Personality DisorderPolymorphism (computer science)Impulsive BehaviormedicineHumansIn patientmedicine.symptomPsychiatryPsychologyAssociation (psychology)Borderline personality disorderGenetic Association StudiesBiological PsychiatryJournal of Psychiatric Research
researchProduct